When: Thursday, March 1, 2018 – doors open at 5:30 p.m.

WHERE: The Commons at Baxter& Love Lane (Journey Church), 1794 Baxter Lane; East Bozeman, MT 59718

About Our Speaker, Dr. Theresa Deisher

Dr. Theresa Deisher’s career has focused on discovering and developing new therapies for grievous human illnesses. She holds a Ph.D. in molecular and cellular physiology from Stanford         University and worked for more than 20 years in the commercial biomedical industry. As her respect for the unborn grew, so did her intolerance for working in a field where experimenting on material from aborted babies is rampant. She is now the president of Sound Choice Pharmaceutical Institute (SCPI) and CEO of AVM Biotechnology. AVM Biotechnology is the marquee pro-life biotech company worldwide, certifying that it does not use morally illicit material in any process. SCPI’s mission is to end human trafficking in biomedical research.

Dr. Deisher is an inventor on 23 issued US patents, and her discoveries have led to clinical trials for FGF18 for osteoarthritis and cartilage repair, and for Factor XIII for surgical bleeding. Dr. Deisher was the first person to discover adult cardiac-derived stem cells and has been a champion of adult stem cell research, both professionally and privately, for two decades.

In 2015, David Daleiden released videos showing Planned Parenthood officials discussing fees for human fetal tissue and organs. Daleiden schmoozed and lunched with people at the top of Planned Parenthood and procurement agencies. Dr. Deisher helped to prepare David Daleiden for his role in these videos. She taught him the ins and outs of being a biomedical representative.

Underwriting opportunities available please call Kelsie at 406-388-7035. Underwriters will get two tickets to attend a VIP session to meet our speaker. For questions, please call the office at 406-388-7035.

 

Registration is now closed.